Faculty

Institution

Unit

Venue

Amanda Marzo

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

Rush University

NoneAmanda Marzo is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Amanda Marzo

Rush University

You can click a keyword to filter the displayed items

immunology cell biology immune responses cellular immune responses immunotherapy cell research adaptive immune system cellular therapy cancer immunotherapy immunological memory oncology infectious diseases immunity (medicine) cell death cancer cells cancer immunosurveillance immunomodulation medicine breast cancer mucosal immunology viral pathogenesis tumor biology cell transplantation antiviral research medical virology viral oncology radiation therapy therapeutic targets medicinal research oncogenes cancer treatment cell therapy host response radiation biology immune checkpoint inhibitors single low dose effector cells cancer care medical mycology thoracic oncology clinical transplantation clinical microbiology molecular cancer cancer discovery therapeutic efficacy tumor targeting clinical immunology host-guest chemistry vaccine research antimicrobial chemotherapy biological therapies cell control cell regulation cell migration virus-host interactions treatment effects cancer risk hematological malignancies myeloid neoplasia anti-cancer agents lymphatic system theranostics intratumoral injection cold tumors future prospects current challenges bacterial-based cancer therapy cd8+ t cells effector responses mucosal tissues combination oncolytic virus influenza virus effector memory icos costimulation anti-cancer responses cancer-specific host death

Notable Scholarly Works

Notable Federal Grants

Collaborators

Il-15 Complexes Combined With Pd-1 Blockade Affect Immune Cell Distribution, Localization, and Immune Signatures in Regressing Versus Non-Regressing Metastatic Breast Tumors. International Journal of Molecular Sciences (2025)

cancer immunotherapybreast cancerimmune responsescancer cellsimmunomodulationil-15 complexesimmune signaturescellular therapyimmunologyimmunotherapyimmune checkpoint inhibitorscell biology

Enhancing Therapeutic Efficacy of Flt3 Inhibitors With Combination Therapy for Treatment of Acute Myeloid Leukemia. International Journal of Molecular Sciences (2024)

acute myeloid leukemiapharmacologymedicineoncogenesoncologyhematological malignanciesleukemiapharmacotherapyanti-cancer agentsmyeloid neoplasiahematologycombination therapytherapeutic targetsflt3 inhibitors

Attenuated Dengue Virus Pv001-DV Induces Oncolytic Tumor Cell Death and Potent Immune Responses. Journal of Translational Medicine (2023)

viral pathogenesisvirologymedical virologyinfectious diseasespotent immune responsesvirus researchviral oncologyattenuated dengueimmunologyimmune responsescell death

Combination Oncolytic Virus, Radiation Therapy, and Immune Checkpoint Inhibitor Treatment in Anti-Pd-1-Refractory Cancer. Journal for ImmunoTherapy of Cancer (2023)

Sachin R JhawarShang-Jui WangAditya ThandoniPraveen K BommareddyJenna H NewmanEileena F GiuriniAmanda L MarzoTimothy M KuzelVineet GuptaJochen ReiserPreston DanielsDevora SchiffDarrion MitchellNicole R LeBoeufChristopher SimmonsSharad GoyalAhmed LasfarJose A Guevara-PatinoBruce G HafftyHoward L KaufmanAnn W SilkAndrew Zloza

cancer immunotherapycancer treatmentmedicineoncologyradiation oncologyradiation therapyviral oncologyimmunotherapycombination oncolytic virus

Intratumoral Influenza Vaccine Administration Attenuates Breast Cancer Growth and Restructures the Tumor Microenvironment Through Sialic Acid Binding of Vaccine Hemagglutinin. International Journal of Molecular Sciences (2023)

vaccine developmentvaccinesvirus eradicationbreast cancerinfectious diseasestherapeutic vaccinessialic acid bindingtumor microenvironmentvaccine hemagglutininimmunologyantiviral researchinfluenza vaccinevaccinationvaccine designinfluenza

Attenuated Dengue Virus Pv001-DV Induces Oncolytic Cell Death and Potent Anti-Tumor Immunity. bioRxiv (Cold Spring Harbor Laboratory) (2022)

Josef W. GoldufskyPreston DanielsMichael D. WilliamsKajal GuptaBruce LydayTony ChenGeeta SinghAndrew ZlozaAmanda L. Marzo

immunity (medicine)cancer immunotherapyviral pathogenesisvirologyinfectious diseasesoncologyvirus researchmolecular biologyantiviral therapypotent anti-tumor immunityimmunologyantiviral researchantiviral responsesimmune responsesnovel therapiescell deathcancer-associated virus

Tracking Fluorescently Labeled Il-15 and Anti-Pd-1 in the Tumor Microenvironment and Draining Lymph Nodes. Journal of Immunological Methods (2022)

cancer immunotherapymolecular imagingcancer imagingcancer cellslymphatic systemtumor microenvironmenttheranosticslymph nodescellular therapycell researchimmunologyimmunotherapyimmune checkpoint inhibitorscell biologycancer immunosurveillance

Bacterial-Based Cancer Therapy (Bbct): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy. Vaccines (2021)

Kajal H. GuptaChristina NowickiEileena F. GiuriniAmanda L. MarzoAndrew Zloza

future prospectsclinical microbiologymolecular cancermicrobiologybiological therapiesbacteriabacterial-based cancer therapytumor biologycancer treatmentinfectious diseasesoncologyimmunologyimmunotherapycancer immunosurveillancecancer immunotherapyoncogenesantimicrobial chemotherapycancer discoverycurrent challengesvaccine researchmedicinal research

Dengue Virus Induces Human Immune Cells to Secrete Factors Capable of Tumor Cell Killing and Activation of Effector Cells Against Treatment-Resistant Tumors. The Journal of Immunology (2021)

immunity (medicine)viral pathogenesisimmune responsesvirologyinfectious diseasesmedical virologytumor celltreatment-resistant tumorsvirus researcharboviruseffector cellsimmunotherapyimmunologyantiviral responsescell biologycell death

Intratumoral Injection of the Seasonal Flu Shot Converts Immunologically Cold Tumors to Hot and Serves as an Immunotherapy for Cancer. Proceedings of the National Academy of Sciences (2019)

Jenna H. NewmanC. Brent ChessonNora L. HerzogPraveen K. BommareddySalvatore M. AspromonteRussell PepeRicardo EstupinianMones M. AboelattaStuti BuddhadevSaeed TarabichiMichael LeeShengguo LiDaniel J. MedinaEileena F. GiuriniKajal H. GuptaGabriel Guevara-AlemanMarco RossiChristina NowickiAbdulkareem AbedJosef W. GoldufskyJoseph R. BroucekRaquel E. RedondoDavid RotterSachin R. JhawarShang-Jui WangFrederick J. KohlhappHoward L. KaufmanPaul G. ThomasVineet GuptaTimothy M. KuzelJochen ReiserJoyce ParasMichael P. KaneEric A. SingerJyoti MalhotraLisa K. DenzinDerek B. Sant’AngeloArnold B. RabsonLeonard Y. LeeAhmed LasfarJohn LangenfeldJason M. SchenkelMary Jo FidlerEmily S. RuizAmanda L. MarzoJai S. RudraAnn W. SilkAndrew Zloza

cold tumorstumor targetingmedicineclinical transplantationscientific communicationhost-guest chemistrytumor biologyclinical immunologyintratumoral injectionpharmacologymedical mycologyoncologyimmunotherapyimmunologycancer immunosurveillancecancer carecancer immunotherapytherapeutic efficacythoracic oncologymedicinal research

1
2
3
4
10 / page

Amanda Marzo

Rush University

Affiliations

Division Of Hematology/Oncology/Cell Therapy

Rush University

NoneAmanda Marzo is currently serving as a Division Of Hematology/Oncology/Cell Therapy faculty at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Amanda Marzo

Rush University

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

cancer immunotherapybreast cancerimmune responsescancer cellsimmunomodulationil-15 complexesimmune signaturescellular therapyimmunologyimmunotherapyimmune checkpoint inhibitorscell biology

Enhancing Therapeutic Efficacy of Flt3 Inhibitors With Combination Therapy for Treatment of Acute Myeloid Leukemia. International Journal of Molecular Sciences (2024)

Attenuated Dengue Virus Pv001-DV Induces Oncolytic Tumor Cell Death and Potent Immune Responses. Journal of Translational Medicine (2023)

viral pathogenesisvirologymedical virologyinfectious diseasespotent immune responsesvirus researchviral oncologyattenuated dengueimmunologyimmune responsescell death

Combination Oncolytic Virus, Radiation Therapy, and Immune Checkpoint Inhibitor Treatment in Anti-Pd-1-Refractory Cancer. Journal for ImmunoTherapy of Cancer (2023)

cancer immunotherapycancer treatmentmedicineoncologyradiation oncologyradiation therapyviral oncologyimmunotherapycombination oncolytic virus

Attenuated Dengue Virus Pv001-DV Induces Oncolytic Cell Death and Potent Anti-Tumor Immunity. bioRxiv (Cold Spring Harbor Laboratory) (2022)

Josef W. GoldufskyPreston DanielsMichael D. WilliamsKajal GuptaBruce LydayTony ChenGeeta SinghAndrew ZlozaAmanda L. Marzo

Tracking Fluorescently Labeled Il-15 and Anti-Pd-1 in the Tumor Microenvironment and Draining Lymph Nodes. Journal of Immunological Methods (2022)

Bacterial-Based Cancer Therapy (Bbct): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy. Vaccines (2021)

Kajal H. GuptaChristina NowickiEileena F. GiuriniAmanda L. MarzoAndrew Zloza

Dengue Virus Induces Human Immune Cells to Secrete Factors Capable of Tumor Cell Killing and Activation of Effector Cells Against Treatment-Resistant Tumors. The Journal of Immunology (2021)

Intratumoral Injection of the Seasonal Flu Shot Converts Immunologically Cold Tumors to Hot and Serves as an Immunotherapy for Cancer. Proceedings of the National Academy of Sciences (2019)

1
2
3
4
10 / page